You have successfully logged out.

menu
close

Drug Compounding in Hospital Pharmacy

Compounding of Medication

Hospital Pharmacies are responsible for the safe and accurate compounding of medication. This compounding can be performed either manually, or with the help of automation and robotics. Which method is used depends entirely on the type and quality of drugs that need to be prepared. Each of these production methods are associated with their own risks and benefits.

B. Braun's extensive portfolio focuses on helping hospital pharmacies compound drugs accurately and safely irrespective of how they are produced.

Manual Drug Preparation

Image is temporarily not available.

Unintended exposure of a health care professionals

One risk factor of manual compounding

Chemical Contamination
chevron_rightRead more

Products for hazardous drug preparation

Products for non-hazardous drug preparation

Products for hazardous drug preparation

[1] Carrez L, Falaschi L, Cingria L, Sadeghipour F, Bouchoud L, Bonnabry P. Organisation et sécurisation du circuit des chimiothérapies: exemple de la pharmacie des Hôpitaux Universitaires de Genève. Pharmactuel 2014;47: 119–24.

[2] Soumoy L, Hecq JD. Automated Compounding of Intravenous Therapy in European Countries: A Review in Pharmaceutical Technology in Hospital Pharmacy 2019;4(2): 51-57. https://doi.org/10.1515/pthp-2019-0008.

[3] Seger AC, Churchill WW, Keohane CA, Belisle CD, Wong ST, Sylvester KW, et al. Impact of robotic antineoplastic preparation on safety, workflow, and costs. J Oncol Pract 2012;8: 344–9.

[4] Banasser G, Karpow C, Gaunt MJ, Grissinger M. Medication Errors in Outpatient Hematology and Oncology Clinics. Pa Patient Saf Advis 2017;14(4).

[5] Kromhout H, Hoek F, Uitterhoeve R, Huijibers R, Overmars RF, Anzion R, Vermeulen R. Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys. Ann Occup Hyg 2000;44(7): 551-60.

[6] Schierl R, Böhlandt A, Nowak D. Guidance Values Surface Monitoring of Antineoplastic Drugs in German Pharmacies. Occup Hyg 2009;53(7): 703-711.

[7] Gielen K, Goossens A. Occupational allergic contact dermatitis from drugs in healthcare workers. Contact Dermatitis 2001;45(5): 273-9.

[8] Swedish Work Environment Authority. Microbiological Work Environment Risks – Infection, Toxigenic Effect, Hypersensitivity. AFS 2005:1.

person_outline Attend survey now!
chevron_right
Back to Top arrow_upward